Literature DB >> 11144898

Epidemiology of human papillomavirus infection.

J Dillner1, C J Meijer, G von Krogh, S Horenblas.   

Abstract

Anogenital human papillomavirus (HPV) infection is a sexually transmitted disease (STD) that typically follows a self-limiting transient course for both sexes. The HPV incidences and prevalences vary greatly, because they reflect the sexual activity of the individuals studied and of the population they are in contact with. Higher prevalences are seen in young, sexually active groups and in high-risk areas for cervical and penile cancer, e.g. in Colombia. There has also been an increasing trend with time in Western Europe, paralleling the spread of other STDs and changes in sexual behavior. Penile intraepithelial neoplasia is usually positive for high-risk HPV DNA, mostly of type 16, whereas only approximately 50% of invasive penile cancers are positive for HPV DNA. This is similar to the role of high-risk HPV in vulvar carcinoma, where the attributable proportion is also approximately 40-50%. Moreover, in both sites similar histologic types of squamous cell carcinoma, i.e. the basoloid and basaloid/warty types, are mainly associated with high-risk HPV types. The studies performed so far have indicated that HPV has an etiological role in penile cancer, although the attributable proportion may be only approximately 40-50%.

Entities:  

Mesh:

Year:  2000        PMID: 11144898

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  9 in total

1.  Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population.

Authors:  M Paz Cañadas; F Xavier Bosch; M Luisa Junquera; Maijo Ejarque; Rebeca Font; Elena Ordoñez; Silvia de Sanjosé
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 2.  [Systemic therapy of penile cancer].

Authors:  E Preis; P Albers; G Jakse
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639

Review 3.  [Options in palliative therapy for penile cancer].

Authors:  E Preis; G Jakse
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

4.  Relationship between hWAPL polymorphisms and cervical cancer susceptibility.

Authors:  Li Li; Gen-Long Jiao; Shuang Qin; Qing Xiao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Histological characteristics of human papilloma-virus-positive and -negative invasive and in situ squamous cell tumours of the penis.

Authors:  Dorrit Krustrup; Helle Lone Jensen; Adriaan J C van den Brule; Morten Frisch
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

6.  CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.

Authors:  Daniel C Worth; Ankur Chakravarthy; Andrew Feber; Patricia de Winter; Kunal Shah; Manit Arya; Muhammad Saqib; Raj Nigam; Peter R Malone; Wei Shen Tan; Simon Rodney; Alex Freeman; Charles Jameson; Gareth A Wilson; Tom Powles; Stephan Beck; Tim Fenton; Tyson V Sharp; Asif Muneer; John D Kelly
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

7.  Molecular diagnosis of human papillomavirus: comparison between cervical and vaginal sampling.

Authors:  R R Finan; N Irani-Hakime; H Tamim; W Y Almawi
Journal:  Infect Dis Obstet Gynecol       Date:  2001

8.  Somatic mutations of STK11 gene in human papillomavirus positive and negative penile cancer.

Authors:  Clorinda Annunziata; Luigi Buonaguro; Simona Losito; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Infect Agent Cancer       Date:  2013-01-10       Impact factor: 2.965

9.  Testicular cancer and HPV semen infection.

Authors:  Andrea Garolla; Damiano Pizzol; Alessandro Bertoldo; Marco Ghezzi; Umberto Carraro; Alberto Ferlin; Carlo Foresta
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-21       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.